Learn how personalized cancer vaccines work and what to watch for at ESMO 2026. A vaccine made from a person’s own tumor has become the first of its kind to succeed in a phase 3 trial. Full results ...

A personalized mRNA cancer vaccine combined with the immunotherapy Keytruda succeeded in a late-stage trial for the deadly skin cancer melanoma, its makers said Wednesday, potentially opening up a new ...

Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.

The personalized mRNA shot teaches the body to attack a patient’s specific melanoma cells A new vaccine could soon protect patients from returning skin cancer. In a large clinical trial, patients with ...

A carefully designed clinical trial that set out to supercharge the immune system’s attack on advanced melanoma has delivered ...

A personalized melanoma vaccine paired with an immune checkpoint drug cut the risk of the cancer returning by 49 Percent at five years in a key clinical trial, according to researchers involved in the ...

MRNA, BNTX and NVAX shares rally after reports of a planned NIH-backed initiative to accelerate personalized cancer vaccines ...

A cancer vaccine may be closer to reality now. Moderna and Merck announced this week that their personalized mRNA melanoma vaccine met key goals in a Phase 3 trial, reducing the risk of the cancer ...

Laura Ferris urges risk-based melanoma screening and highlights earlier immunotherapy, selective imaging, vaccine limits and ...

Researchers are testing a vaccine approach that may change future cancer treatment.

A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the companies behind the trial announced this week. The vaccine — which relies on the ...

Moderna stock has surged nearly 600% this year on a cancer vaccine trial result that almost no one outside the trial has ...